CAS 1820817-64-8

Methanesulfonato{[4-(N,N-dimethylamino)phenyl]di-t-butylphosphino}(2'-amino-1,1'-biphenyl-2-yl)palladium(II), min. 98% [Amphos Palladacycle Gen. 3]

CAS: 1820817-64-8

Methanesulfonato{[4-(N,N-dimethylamino)phenyl]di-t-butylphosphino}(2'-amino-1,1'-biphenyl-2-yl)palladium(II), min. 98% [Amphos Palladacycle Gen. 3]

Fórmula: C₂₉H₄₁N₂O₃PPdS

Pureza: min. 98%

Cor e Forma: beige to tan pwdr.

Peso molecular: 635.11

Ref: 08-46-0345

Methanesulfonato{[4-(N,N-dimethylamino)phenyl]di-t-butylphosphino}(2'-amino-1,1'-biphenyl-2-yl)palladium(II), min. 98% [Amphos Palladacycle Gen. 3]

CAS: 1820817-64-8

Fórmula: C₂₉H₄₁N₂O₃PPdS

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 635.1062

Ref: IN-DA01FR0N

Methanesulfonato{[4-(N,N-DimethylAmino)Phenyl]di-t-Butylphosphino}(2-Amino-1,1-biPhenyl-2-yl)Palladium(II)

CAS: 1820817-64-8

Methanesulfonato{[4-(N,N-DimethylAmino)Phenyl]di-t-Butylphosphino}(2-Amino-1,1-biPhenyl-2-yl)Palladium(II)

Pureza: 98%

Peso molecular: 635.11g/mol

Ref: 54-IN10547

APhos Pd G3

CAS: 1820817-64-8

Pureza: 98%

Peso molecular: 634.16

Ref: 10-F551854

APhos Pd G3

CAS: 1820817-64-8

APhos Pd G3 is a drug with a bicyclic structure. It is an inhibitor of ganglion cells and has been shown to have a positive effect on the symptoms of dementia, psychosis, and psychiatric disorders. It has also been shown to be beneficial in the treatment of Parkinson's disease, which is characterized by the loss of dopaminergic neurons. APhos Pd G3 prevents neuronal cell death by inhibiting monoamine oxidase-B (MAO-B), which breaks down dopamine. This leads to increased levels of dopamine in the striatum and improved motor function. APhos Pd G3 also blocks MAO-A, which breaks down serotonin, norepinephrine, and epinephrine. The inhibition of MAO-A leads to increased levels of serotonin and norepinephrine in the brainstem and spinal cord.

Fórmula: C₂₉H₄₁N₂O₃PPdS

Pureza: Min. 95%

Peso molecular: 635.11 g/mol

Ref: 3D-VXC81764